Zen-Bio Inc

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatment for people with life-threatening disorders. The company s wholly owned subsidiary, Talecris Plasma Resources, is a national network of plasma collection centers that provides the source material for the production of critical care protein therapies. Talecris Biotherapeutics employs more than 4,300 people worldwide. The company is licensed to do in-house nucleic acid testing for hepatitis C, hepatitis B and human immunodeficiency virus. It offers aseptic filling, plasma fractionation and pharmaceutical compounding, as well as extraction, concentration and purification services for complex molecules. Talecris Biotherapeutics sponsors external research grant programs.

Founded in 1995, Zen-Bio is a leading provider of research tools for the study of human metabolic disease. The company has an established customer base of more than 1,000, and performs contract research for major pharmaceutical and biotechnology companies throughout the world. It pioneered tissue engineering with adult adipose-derived stem cells and researches the role obesity plays in the development and onset of metabolic disease. Its mission is to provide the highest quality cells, reagents and contract services to the biomedical research community; to develop and commercialize research tools; and to leverage its expertise in this field into successful treatments for metabolic diseases through research and development and strategic alliances. Zen-Bio is located in Durham, N.C.